The findings presented in this paper suggest that based on diagnostic characteristics of all proteins tested, serum CXCL8 might be used as a potential biomarker in the diagnosis of GC patients, especially in a combined assessment with classical tumor markers. The gene discussed is CXCL8; the disease is neoplasm.